Literature DB >> 1459337

Interaction of the 90-kDa heat shock protein with native and in vitro translated androgen receptor and receptor fragments.

S Marivoet1, P Van Dijck, G Verhoeven, W Heyns.   

Abstract

Androgen receptor (AR) from rat ventral prostate and AR synthesized in vitro by translation in rabbit reticulocyte lysate of AR mRNA, transcribed from a pGEM-4Z DNA template were compared by gel permeation chromatography and by sucrose gradient ultracentrifugation. Under non-activating conditions the AR from rat prostate migrated as an 8-9 S complex of approx. 300 kDa. The addition of chicken antibodies against HSP90 shifted this complex to the void volume of the column or to the bottom of the ultracentrifugation gradient. Under activating conditions, on the other hand, the AR migrated as a 110 kDa, 5.2 S protein and was no longer displaced by HSP90 antibodies. Under all these conditions, the behaviour of in vitro synthesized AR was very similar to that of AR from rat prostate. By selective use of restriction enzymes on the template of transcription AR mutants could be prepared from which an increasing part was deleted at their carboxy terminal end. The interaction with HSP90 was conserved for AR1-758 missing the last 145 amino acids, but was lost in AR1-703. Furthermore, a large internal deletion (ARd41-469) of the major part of the amino terminal half of the AR did not result in the loss of HSP90 binding. These results indicate that a specific subregion (amino acids 704-758) of the carboxy terminal half of the AR is required for the interaction with HSP90.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1459337     DOI: 10.1016/0303-7207(92)90021-w

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  14 in total

1.  The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells.

Authors:  Anthony J Saporita; Junkui Ai; Zhou Wang
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

2.  Inhibition of androgen receptor-mediated transcription by amino-terminal enhancer of split.

Authors:  X Yu; P Li; R G Roeder; Z Wang
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.

Authors:  Vicki Gordon; Shriti Bhadel; Winfried Wunderlich; JoAnn Zhang; Scott B Ficarro; Sahana A Mollah; Jeffrey Shabanowitz; Donald F Hunt; Ioannis Xenarios; William C Hahn; Mark Conaway; Michael F Carey; Daniel Gioeli
Journal:  Mol Endocrinol       Date:  2010-10-27

4.  A naturally derived small molecule disrupts ligand-dependent and ligand-independent androgen receptor signaling in human prostate cancer cells.

Authors:  Karishma S Amin; Shankar Jagadeesh; Gakul Baishya; Paruchuri G Rao; Nabin C Barua; Samir Bhattacharya; Partha P Banerjee
Journal:  Mol Cancer Ther       Date:  2013-11-20       Impact factor: 6.261

5.  Differential in vivo regulation of steroid hormone receptor activation by Cdc37p.

Authors:  A E Fliss; Y Fang; F Boschelli; A J Caplan
Journal:  Mol Biol Cell       Date:  1997-12       Impact factor: 4.138

Review 6.  The AR dependent cell cycle: mechanisms and cancer relevance.

Authors:  Matthew J Schiewer; Michael A Augello; Karen E Knudsen
Journal:  Mol Cell Endocrinol       Date:  2011-07-12       Impact factor: 4.102

7.  Hsp90 regulates the phosphorylation and activity of serum- and glucocorticoid-regulated kinase-1.

Authors:  Larissa Belova; Deanna R Brickley; Betty Ky; Sanjay K Sharma; Suzanne D Conzen
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

8.  Transcriptional activity of c-Jun is critical for the suppression of AR function.

Authors:  Chih-Chao Hsu; Chang-Deng Hu
Journal:  Mol Cell Endocrinol       Date:  2013-03-21       Impact factor: 4.102

9.  Human androgen receptor expressed in HeLa cells activates transcription in vitro.

Authors:  P De Vos; J Schmitt; G Verhoeven; H G Stunnenberg
Journal:  Nucleic Acids Res       Date:  1994-04-11       Impact factor: 16.971

10.  Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer.

Authors:  Michael A Moses; Yeong Sang Kim; Genesis M Rivera-Marquez; Nobu Oshima; Matthew J Watson; Kristin E Beebe; Catherine Wells; Sunmin Lee; Abbey D Zuehlke; Hao Shao; William E Bingman; Vineet Kumar; Sanjay V Malhotra; Nancy L Weigel; Jason E Gestwicki; Jane B Trepel; Leonard M Neckers
Journal:  Cancer Res       Date:  2018-05-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.